Navigation Links
Initial Survey Findings on Diabetes Awareness Released by

Patient Assistance ( has released initial survey results on diabetes awareness amongst uninsured and underinsured Americans.

Baton Rouge, LA – November 20, 2008 – Patient Assistance releases initial findings of a survey on diabetes awareness amongst the predominantly uninsured and underinsured visitors of Highlights include the fact that more than half of the more than 1000 unique respondents do not know their blood glucose level.

Increasing awareness of an individual’s blood glucose level is the foundation of the National Diabetes Goal, which aims to have 45% of at-risk Americans aware of their blood glucose level by 2015. Patient Assistance is a National Diabetes Goal Champion, pledging to raise awareness about diabetes and help turn that awareness into action.
Full results of the first two weeks of the survey are as follows:

  • 32% of respondents have been told by a doctor or other medical professional that they are at-risk for diabetes.
  • 12% of respondents feel they are at-risk of diabetes.
  • 62% of respondents have been tested for diabetes.
  • 44% of respondents know their blood glucose level.
  • 69% of respondents feel there are actions they can take to prevent and / or manage diabetes.
  • The most common ways respondents feel diabetes can be prevented or managed include diet, exercise, and medications.

“Our survey results are an enlightening look at the current level of diabetes awareness, specifically among the uninsured,” says Rex Bowden, President of, Inc. “We’re seeing that many of the uninsured aren’t even aware of their blood glucose level, and that a relatively small percentage of respondents consider themselves at-risk of diabetes. What we’re also seeing is that the majority of the uninsured do believe they can make a difference in preventing the onset of the disease, and that many are aware of options available to them, including those options not requiring medical services or medications which may not be as accessible to those without medical insurance.”

The survey is being conducted through, and began on November 1st. These initial findings are based on data gathered from 1058 unique and voluntary visitors to the site. The survey data will continue to be gathered until a total of 5000 unique survey respondents is reached.

About is a nonprofit organization providing information on thousands of patient assistance programs to help users better manage, and reduce, prescription drug costs. Users can search by medication or for specific patient assistance programs, which are updated on a regular basis. The site offers patients a variety of tools including local drug pricing information, the ability to track programs the user is currently enrolled in, and reminders when patients need to resubmit enrollment forms to the pharmaceutical manufacturers. helps consumers find patient assistance programs, supply enrollment forms, and track their re-enrollments all in one place. For more information about the National Diabetes Goal, please visit For more information about or to take part in the diabetes awareness and prevention survey, please visit, or contact Rex Bowden at 225-266-7941.


Read the full story at

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Lilly Announces Major Donation of Insulin to International Diabetes Federations Life for a Child Program; Initial Focus Will Be on Sub-Saharan Africa
2. HMS Holdings Corp. Announces Q3 2008 Results, 2008 Revised Guidance and Initial 2009 Guidance
3. Response Biomedical Completes Initial Closing of an expected $5.0 Million Financing
4. Nanobiotix and BiotechCorp Announce Initial Focus of Their Collaboration: P-O-C Diagnostics and Drug Delivery Systems for Tropical Diseases, Such as Malaria
5. Rivulet Communications Announces New Technical Advisory Board and Initial Board Appointments
6. AutoGenomics, Inc. Files Registration Statement for Initial Public Offering
7. Economist Finds Highmark/IBC Merger Would Result in 70 Percent Share in Pennsylvania, Far Higher Than Initial Reports
8. Genomma Lab Prices Initial Public Offering and Begins Trading on Mexican Stock Exchange
9. New model predicts whether patients will be free of renal cancer 12 years after initial treatment
10. Medipacs Initial Financing
11. Innolife Pharma Provides Initial Update on Negotiations for Significant Product Joint Venture
Post Your Comments:
Related Image:
Initial Survey Findings on Diabetes Awareness Released by
(Date:10/13/2017)... WI (PRWEB) , ... October 13, 2017 , ... As ... in medicine known as “patient engagement.” The patient is doing more than filling out ... partners. , “There is an increasing emphasis in health care and research on ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along ... updates for the primary prevention of cardiovascular diseases during the 15th Annual ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a ... targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , ...
Breaking Medicine Technology: